NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
Clinical trial NCT00142454 · COMPLETED
Trial details
- NCT number
- NCT00142454
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-24
- Primary completion
- 2006-04-25
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.